These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6244352)

  • 1. A type-specific antiserum induced bya major herpesvirus type 1 glycoprotein.
    Ching CY; López C
    J Immunol Methods; 1980; 32(4):383-91. PubMed ID: 6244352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins.
    Eing BR; Kühn JE; Braun RW
    J Med Virol; 1989 Jan; 27(1):59-65. PubMed ID: 2466100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody.
    Glorioso JC; Wilson LA; Fenger TW; Smith JW
    J Gen Virol; 1978 Aug; 40(2):443-54. PubMed ID: 211189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a herpes simplex virus-specific antigenic fraction which stimulates the production of neutralizing antibody.
    Cohen GH; Ponce de Leon M; Nichols C
    J Virol; 1972 Nov; 10(5):1021-30. PubMed ID: 4344251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of herpesvirus type-specific antibody by a micro solid phase radioimmunometric assay.
    Dreesman GR; Matson DO; Courtney RJ; Adam E; Melnick JL
    Intervirology; 1979; 12(2):115-9. PubMed ID: 94044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and biochemical analysis of gB of herpes simplex virus type 1 and type 2 and of cross-reacting glycoproteins induced by bovine mammillitis virus and equine herpesvirus type 1.
    Snowden BW; Kinchington PR; Powell KL; Halliburton IW
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():231-47. PubMed ID: 2981966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on Helix pomatia lectin-purified antigens.
    Suchánková A; Hirsch I; Krĕmár M; Vonka V
    J Infect Dis; 1984 Jun; 149(6):964-72. PubMed ID: 6330240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cross-reacting glycoproteins of four herpesviruses by Western blotting.
    Snowden BW; Halliburton IW
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():2039-44. PubMed ID: 2993488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV).
    Shiraki K; Okuno T; Yamanishi K; Takahashi M
    J Gen Virol; 1982 Aug; 61 (Pt 2)():255-69. PubMed ID: 6288857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.
    Powell KL; Buchan A; Sim C; Watson DH
    Nature; 1974 May; 249(455):360-1. PubMed ID: 4135313
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoblotting and ELISA analysis of HSV-1 and HSV-2-specified polypeptides by using an immunoblocking method.
    Lehtinen M
    Ann Clin Res; 1985; 17(2):66-70. PubMed ID: 2412480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteins with type common and type specific antigenic sites excreted from cells infected with herpes simplex virus types 1 and 2.
    Randall RE; Killington RA; Watson DH
    J Gen Virol; 1980 Jun; 48(Pt 2):297-310. PubMed ID: 6156995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
    Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
    J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossed immunoelectrophoresis of a herpes simplex virus type 1-specific antigen: immunological and biochemical characterization.
    Vestergaard BF; Norrild B
    J Infect Dis; 1978 Nov; 138(5):639-43. PubMed ID: 81867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neutralizing and immunoprecipitating activity in guinea pig antisera against Herpes simplex virus types 1 and 2.
    Jeansson S; Vestergaard BF
    Acta Pathol Microbiol Scand B; 1975 Aug; 83(4):343-6. PubMed ID: 168730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
    Jankowski MA; Petersen EE; Böcker JF
    Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
    Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
    J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.